Elcatonin

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Elcatonin
DrugBank Accession Number
DB13742
Background

Not Available

Type
Small Molecule
Groups
Experimental
Synonyms
  • Elcatonin
  • Elcatonina

Pharmacology

Indication

Not Available

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcalabrutinibThe therapeutic efficacy of Elcatonin can be decreased when used in combination with Acalabrutinib.
AcebutololThe risk or severity of adverse effects can be increased when Acebutolol is combined with Elcatonin.
AcetohexamideThe therapeutic efficacy of Acetohexamide can be decreased when used in combination with Elcatonin.
AfatinibThe therapeutic efficacy of Elcatonin can be decreased when used in combination with Afatinib.
AldesleukinThe therapeutic efficacy of Elcatonin can be decreased when used in combination with Aldesleukin.
AlectinibThe therapeutic efficacy of Elcatonin can be decreased when used in combination with Alectinib.
Alendronic acidThe risk or severity of hypocalcemia can be increased when Elcatonin is combined with Alendronic acid.
Aminosalicylic acidThe therapeutic efficacy of Elcatonin can be decreased when used in combination with Aminosalicylic acid.
AmitriptylineThe risk or severity of Cardiac Arrhythmia can be increased when Elcatonin is combined with Amitriptyline.
AmitriptylinoxideThe risk or severity of Cardiac Arrhythmia can be increased when Elcatonin is combined with Amitriptylinoxide.
Interactions
Improve patient outcomes
Build effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.
Learn more
Food Interactions
Not Available

Categories

ATC Codes
H05BA04 — Elcatonin
Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
W0CMS474JK
CAS number
60731-46-6
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

References

General References
Not Available
Wikipedia
Elcatonin

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on June 23, 2017 20:47 / Updated on February 21, 2021 18:54